|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
06185 CANSINOBIO
Nominal 
32.500 -0.150 (-0.459%) Profitability Analysis
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| ROAA (%) | -4.386% | -14.265% | -7.792% | 20.560% | -9.297% |
| ROAE (%) | -7.440% | -24.666% | -12.337% | 27.220% | -10.519% |
| Return on Capital Employed (%) | -6.125% | -22.042% | -10.665% | 21.273% | -6.261% |
Margin Analysis
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Gross Profit Margin (%) | 70.368% | -253.785% | -18.099% | 69.817% | 25.561% |
| EBITDA Margin (%) | -20.968% | -511.302% | -110.450% | 46.771% | -1990.498% |
| Pre-tax Profit Margin (%) | -46.213% | -573.287% | -114.835% | 45.045% | -2138.902% |
| Net Profit Margin (%) | -45.932% | -429.551% | -88.205% | 44.524% | -2138.902% |
Liquidity Analysis
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Current Ratio (X) | 2.417 X | 1.999 X | 2.627 X | 3.231 X | 13.130 X |
| Quick Ratio (X) | 2.258 X | 1.864 X | 2.397 X | 2.927 X | 12.717 X |
Leverage Analysis
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Total Liabilities / Total Assets(%) | 38.304% | 43.261% | 36.824% | 28.013% | 10.036% |
| Total Debt / Total Assets (%) | 25.300% | 28.977% | 23.547% | 11.578% | 2.112% |
| Net Debt / Total Assets (%) | 5.741% | 7.011% | -6.053% | -34.378% | -63.788% |
| Total Debt / Shareholders' Funds (%) | 41.007% | 51.195% | 40.021% | 17.196% | 2.348% |
| Long Term Debt / Shareholders' Funds (%) | 22.632% | 23.525% | 15.950% | 3.288% | 1.545% |
| Net Debt / Shareholders' Funds (%) | 9.306% | 12.387% | -10.287% | -51.057% | -70.904% |
| Net Cash / (Debt) ($) | (456.910M) | (653.343M) | 694.194M | 4.082B | 4.304B |
| Net Cash / (Debt) per share ($) | (1.850) | (2.640) | 2.805 | 16.497 | 17.395 |
| Total Debt / Capital Employed (%) | 32.547% | 40.142% | 31.672% | 15.277% | 2.250% |
| Interest Coverage Ratio (X) | N/A | N/A | N/A | 95.852 X | N/A |
Efficiency Analysis
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Inventory Turnover (Day) | 471.256 Day | 153.692 Day | 232.822 Day | 147.113 Day | 2470.308 Day |
| Receivables Turnover (Day) | 304.100 Day | 789.027 Day | 179.380 Day | 7.622 Day | 425.919 Day |
| Payables Turnover (Day) | 36.825 Day | 188.796 Day | 193.943 Day | 38.334 Day | 656.858 Day |
| Remarks: | Real time quote last updated: 08/05/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -378,884,000 |
| %Change | -74.447% |
| EPS / (LPS) | RMB -1.530 |
| NBV Per Share (¥) | RMB 19.874 |